Taken together, these data support an important role of ANG II in vascular lipid accumulation, CML and RAGE levels in the context of experimental dietary LS and systemic RAAS activation. The gene discussed is AGER; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.